• New Zealand-based Kitea Health has secured placement in the FDA fast-track program, accelerating the regulatory pathway for their innovative medical sensor technology.
• The company recently achieved a world-first by successfully implanting their neural sensor into a child's brain, marking a significant milestone in pediatric neurosurgical interventions.
• Kitea Health has raised $7 million toward a $10 million funding round, building on a decade of research before commercialization of their technology.